Japan's Healios Progresses Novel Cell Therapy For ARDS

Activity in Japan's cell and regenerative therapy space continues apace as venture starts trial with lead development asset for acute respiratory distress syndrome.

Stem cell
Healios Begins Cell Therapy Trial For ARDS • Source: Shutterstock

Adding to a flurry of activity around cell and regenerative therapies in Japan over the past few months, local venture Healios KK has begun recruiting for a clinical trial with a novel cell therapy for acute respiratory distress syndrome (ARDS).

The development suggests that the environment for such products in the country continues to be positive, despite some rumblings that...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia